Another popular weight loss medication starting to make waves in the news is Mounjaro (Trizepatide). This weight loss treatment is similar to Semaglutide. Mounjaro, like Semaglutide, is an incretin mimetic treatment. However, it is different. Mounjaro acts on GIP and GLP-1 receptors—Semaglutide only works on GLP-1.
Mounjaro is a dual-acting GIP and GLP-1. It lowers fasting and postprandial glucose concentrations. In addition, it decreases food intake, reduces body mass, and improves the health of patients with weight-related issues, including type-2 diabetes.
If you wonder which weight loss medication is best for you, speak to the professionals at Vvitality360. Gaining as much knowledge as possible about your weight loss treatment options is important. No matter which treatment you begin, you should never use these medicines with other GLP-1 or GIP receptor agonists.